Teen leukemia survivor fundraises for cancer, gene therapy In her last two years of high school, 17-year-old Nicole Graham went from being a tri-varsity athlete to a leukemia patient. Now, as a survivor, she’s taken on yet another role: cancer therapy advocate
Dying teen 'coughs up tumor' A terminally-ill teenager, whose cancer charity appeal has won worldwide support and admiration, has revealed his condition "dramatically improved" after he "coughed up a tumor."
The US is about to get Cuba's lung cancer vaccine Closer American ties with one of the world's major cigar exporters could actually be good news in the fight against lung cancer.
Michigan-based martial arts program helps kids kick cancer The young people who learn martial arts at a studio north of Detroit are not considered students.
With gene mutations, second breast cancer risk rises over time Women who are genetically susceptible to breast cancer and develop it in one breast are at higher than average risk for a tumor in the other breast, and that risk may increase as time goes on, according to a new analysis.
Lung cancer screening could cost Medicare billions, study shows Every person covered by Medicare would shell out an additional $3 a month if the government agreed to pay to screen certain current and former smokers for lung cancer, a new study estimates.
Jessica Alba’s company under fire as customers complain sunscreen doesn’t work Jessica Alba’s Honest Company has come under fire from customers who say one of its sunscreens doesn’t protect against the sun’s harmful UV rays.
Calcium, vitamin D pills don't prevent colon growths, study says A major study finds that taking calcium or Vitamin D pills does not help prevent growths that can lead to colon cancer in people who have had at least one in the past.
Utah mom of 6 given 24 hours to live defies odds, returns home A Utah mother says her faith and family have helped her through an ordeal that saw her lose her infant son, and exceed doctors’ expectations after being given just 24 to 36 hours to live.
GlaxoSmithKline lung drug fails to extend life in huge study GlaxoSmithKline's inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a high-stakes clinical trial of 16,500 people, torpedoing hopes of a sales boost for the drug.